Gastroenterology
Volume 139, Issue 3 , Pages 779-787.e1 , September 2010

Inflammatory Bowel Disease Is a Risk Factor for Recurrent Venous Thromboembolism

  • Gottfried Novacek

      Affiliations

    • Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationReprint requests Address requests for reprints to: Gottfried Novacek, MD, Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Waehringer Guertel 18-20, A-1090 Vienna, Austria. fax: +43 (1) 40400 4735
    • ,
  • Ansgar Weltermann

      Affiliations

    • Department of Internal Medicine 1, Elisabethinen Hospital Linz, Linz, Austria
    • ,
  • Anna Sobala

      Affiliations

    • Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • ,
  • Herbert Tilg

      Affiliations

    • Department of Medicine, Academic Teaching Hospital Hall in Tirol, Hall in Tirol, Austria
    • ,
  • Wolfgang Petritsch

      Affiliations

    • Department of Internal Medicine, Medical University of Graz, Graz, Austria
    • ,
  • Walter Reinisch

      Affiliations

    • Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • ,
  • Andreas Mayer

      Affiliations

    • Department of Internal Medicine, General Hospital of St Pölten, St Pölten, Austria
    • ,
  • Thomas Haas

      Affiliations

    • Department of Internal Medicine 1, Paracelsus Private Medical University, Salzburg, Austria
    • ,
  • Arthur Kaser

      Affiliations

    • Department of Internal Medicine II, Innsbruck Medical University, Innsbruck, Austria
    • ,
  • Thomas Feichtenschlager

      Affiliations

    • Department of Internal Medicine 4, Hospital Rudolfstiftung, Vienna, Austria
    • ,
  • Harry Fuchssteiner

      Affiliations

    • Department of Internal Medicine 4, Elisabethinen Hospital Linz, Linz, Austria
    • ,
  • Peter Knoflach

      Affiliations

    • Department of Gastroenterology, Klinikum Wels, Wels, Austria
    • ,
  • Harald Vogelsang

      Affiliations

    • Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • ,
  • Wolfgang Miehsler

      Affiliations

    • Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • ,
  • Reingard Platzer

      Affiliations

    • Department of Internal Medicine 1, General Hospital of Wiener Neustadt, Wiener Neustadt, Austria
    • ,
  • Wolfgang Tillinger

      Affiliations

    • Department of Internal Medicine 1, General Hospital Hietzing, Vienna, Austria
    • ,
  • Bernhard Jaritz

      Affiliations

    • Department of Internal Medicine 2, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria
    • ,
  • Alfons Schmid

      Affiliations

    • Department of Internal Medicine 2, Danube Hospital, Vienna, Austria
    • ,
  • Benedikt Blaha

      Affiliations

    • Department of Internal Medicine 4, Wilheminenspital der Stadt Wien, Vienna, Austria
    • ,
  • Clemens Dejaco

      Affiliations

    • Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    • ,
  • Sabine Eichinger

      Affiliations

    • Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria

Received 22 January 2010 ,Accepted 13 May 2010.

References 

  1. Sloan W, Bargen A, Gage R. Life histories of patients with chronic ulcerative colitis: a review of 2000 cases. Gastroenterology. 1950;16:25–38
  2. Edwards F, Truelove S. The course and prognosis of ulcerative colitis. III. Complications. Gut. 1964;5:1–15
  3. Talbot RW, Heppell J, Dozois RR, et al. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61:140–145
  4. Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol. 2000;35:619–623
  5. Bernstein CN, Blanchard JF, Houston DS, et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001;85:430–434
  6. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut. 2004;53:542–548
  7. Jackson LM, O'Gorman PJ, O'Connell , et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM. 1997;90:183–188
  8. Solem CA, Loftus EV, Tremaine WJ, et al. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97–101
  9. Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102:609–617
  10. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1–9
  11. Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007;102:174–186
  12. Hudson M, Chitolie A, Hutton RA, et al. Thrombotic vascular risk factors in inflammatory bowel disease. Gut. 1996;38:733–737
  13. Spina L, Saibeni S, Battaglioli T, et al. Thrombosis in inflammatory bowel disease: role of inherited thrombophilia. Am J Gastroenterol. 2005;100:2036–2041
  14. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657–663
  15. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692–699
  16. Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007;147:766–774
  17. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386–1389
  18. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: The Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2004;117:19–25
  19. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guideline (8th edition). Chest. 2008;133(Suppl):454S–545S
  20. Palareti G, Cosmi B. Bleeding with anticoagulation therapy—who is at risk, and how best to identify such patients. Thromb Haemost. 2009;102:268–278
  21. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet. 2005;365(9465):1163–1174
  22. Kyrle P, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–2563
  23. McRae S, Tran H, Schulman S, et al. Effect of patient′s sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet. 2006;368:371–378
  24. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  25. Baron JA, Gridley G, Weiderpass E, et al. Venous thromboembolism and cancer. Lancet. 1998;351:1077–1080
  26. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457–462
  27. Weltermann A, Eichinger S, Bialonczyk D, et al. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28–32
  28. Eichinger S, Hron G, Bialonczyk C, et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med. 2008;168:1678–1683
  29. Vandenbroucke JP, von Elm E, Altmann DG, et al. Strengthening of reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163–W194
  30. Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut. 2006;55(Suppl 1):i1–i15
  31. Stange EF, Travis SPL, Vermeire S, et al. European evidence based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis. 2008;2:1–23
  32. Goteway M, Edinburgh K, Feldstein V, et al. Imaging evaluation of suspected pulmonary embolism. Curr Probl Diagn Radiol. 1999;28:129–184
  33. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA. 1990;263:2753–2769
  34. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5–36
  35. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1(8167):514
  36. Walmsley RS, Ayres RCS, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29–32
  37. Higgins PDR, Schwartz M, Mapili J, et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut. 2005;54:782–788
  38. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132:763–786
  39. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and structuring behaviours in the first 8 years of Crohn's disease. Am J Gastroenterol. 2003;98:363–368
  40. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67
  41. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698–3703
  42. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost. 1995;74:1185–1190
  43. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  44. Whitley E, Ball J. Statistics review 4: sample size calculation. Crit Care. 2002;6:335–341
  45. Eischer L, Eichinger S, Kyrle PA. Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. Medicine (Baltimore). 2009;88:366–370
  46. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoaglation in patients with acute proximal deep vein thrombosis or pulmonary embolism (A prospective cohort study in 1626 patients). Haematologica. 2007;92:199–205
  47. Zhu T, Martinez I, Emmerich J. Venous thromboembolism: risk factors for recurrence. Arterioscler Thromb Vasc Biol. 2009;29:298–310
  48. Danese S, Katz J, Daibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut. 2003;52:1435–1441
  49. Folsom AR, Lutsey PL, Astor BC, et al. C-reactive protein and venous thromboembolism (A prospective investigation in the ARIC cohort). Thromb Haemost. 2009;102:615–619
  50. Shen J, Ran ZH, Tong JL, et al. Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Aliment Pharmacol Ther. 2007;26:653–663

 This article has an accompanying continuing medical education activity on page e12. Learning Objective: Upon completion of this exercise, successful learners will be able to identify the risk of recurrent venous thromboembolism in patients with inflammatory bowel disease.

 Conflicts of interest The authors disclose no conflicts.

 Funding The study received funding through the Medical Scientific Fund of the Mayor of the City of Vienna (project number 2551) and the Hochschuljubiläumsstiftung of the City of Vienna (H-806/2005).

PII: S0016-5085(10)00754-7

doi: 10.1053/j.gastro.2010.05.026

Gastroenterology
Volume 139, Issue 3 , Pages 779-787.e1 , September 2010

Article Tools

* Image Usage & Resolution